Korea Zinc Co., Ltd. will invest $8.3 billion to build an integrated non-ferrous metal smelter in the US, with participation from the US government and strategic investors, aiming to strengthen supply chain security and meet rising demand for critical minerals in North America.
#YonhapInfomax #KoreaZinc #USGovernment #NonFerrousMetals #SupplyChain #InvestmentAmount #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=95575
Korea Zinc to Build $8.3 Billion Non-Ferrous Metal Smelter in US—US Government to Participate (Update)
Korea Zinc Co., Ltd. will invest $8.3 billion to build an integrated non-ferrous metal smelter in the US, with participation from the US government and strategic investors, aiming to strengthen supply chain security and meet rising demand for critical minerals in North America.
Yonhap InfomaxNvidia has invested $1 billion in Nokia, acquiring a 2.9% stake to deepen strategic ties and accelerate the expansion of its AI ecosystem, as both companies target next-generation data center and network infrastructure.
#YonhapInfomax #Nvidia #Nokia #AIEcosystem #DataCenters #InvestmentAmount #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=87722
Nvidia Invests $1 Billion in Nokia to Accelerate AI Ecosystem Expansion
Nvidia has invested $1 billion in Nokia, acquiring a 2.9% stake to deepen strategic ties and accelerate the expansion of its AI ecosystem, as both companies target next-generation data center and network infrastructure.
Yonhap Infomax
Kumho Tire to Build New Plant in Hampyeong to Restore Fire-Damaged Capacity
Kumho Tire Co. will invest 660.9 billion won ($480 million) to build a new plant in Hampyeong, aiming to restore capacity lost in a May fire and strengthen its competitiveness.
Yonhap InfomaxCelltrion will acquire Eli Lilly’s New Jersey biopharmaceutical plant for 460 billion won ($335 million), investing at least 1.4 trillion won ($1.02 billion) to expand US production capacity and fully eliminate tariff risks, with operations set to begin in 2027 pending regulatory approval.
#YonhapInfomax #Celltrion #EliLilly #BiopharmaceuticalPlant #TariffRisk #InvestmentAmount #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=82977
Celltrion Acquires Eli Lilly’s US Plant for 460 Billion Won—“Fully Eliminates Tariff Risk”
Celltrion will acquire Eli Lilly’s New Jersey biopharmaceutical plant for 460 billion won ($335 million), investing at least 1.4 trillion won ($1.02 billion) to expand US production capacity and fully eliminate tariff risks, with operations set to begin in 2027 pending regulatory approval.
Yonhap InfomaxNow IB has invested an additional 3 billion won in YU, a Hurom subsidiary specializing in fillers, bringing its total investment to 11 billion won as YU accelerates global expansion and prepares for a pre-IPO round.
#YonhapInfomax #NowIB #YU #FillerMarket #IPO #InvestmentAmount #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=69605
Now IB Eyes Filler Companies, Makes Third Follow-On Investment in YU
Now IB has invested an additional 3 billion won in YU, a Hurom subsidiary specializing in fillers, bringing its total investment to 11 billion won as YU accelerates global expansion and prepares for a pre-IPO round.
Yonhap Infomax